New data published in the journal Applied Materials and Interfaces (along with media information that should be read with some caution) suggests the possibility of a new way to test for risk of prostate cancer based on the adhesion of citrate-capped gold nanoparticles to biomolecules in truly tiny blood samples. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: blood, Diagnosis, gold, nanoparticles, risk | 1 Comment »
The potential to use magnetically charged nanoparticles as a method to treat a variety of forms of cancer by using the particles to heat and kill tumor cells has been around for several years now. Apparently we are getting a little closer to the application of this technology in the treatment of prostate cancer. … READ MORE …
Filed under: Management | Tagged: magnetic, nanoparticles, nanotechnology | 1 Comment »
In today’s new items we identified items dealing with:
Filed under: Drugs in development, Management, Treatment | Tagged: docetaxel, estramustine, gold, HRPC, nanoparticles, radical prostatectomy, vinorelbine | Leave a comment »
There are a significant number of relatively long-term news items in today’s report. Of most immediate interest to the majority of prostate cancer patients and educators we include reports on:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, curcumin, Degarelix, focal therapy, nanoparticles, PROMIS, sexual function, TRAIL | 3 Comments »
There are a bunch of new but distinctly technical reports today that will probably be of limited interest to the majority of readers, but in the interests of knowledge please feel free to … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: brachytherapy, cisplatin, Her2, interleukin-6, motion, nanoparticles, prostate, radiotherapy, TrkA, urethra | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 